BACTERIAL MENINGITIS BEYOND THE NEONATAL PERIOD

Feigin and Cherry's Textbook of Pediatric Infectious Diseases, Sixth Edition

Volumn , Issue , 2009, Pages 439-471

  Feigin, Ralph D ^a,b,c,d,e   Cutrer, William B ^b,c  

^a Department of Pediatrics ^*  (United States)

^b BAYLOR COLLEGE OF MEDICINE   (United States)

^c TEXAS CHILDREN S HOSPITAL   (United States)

^d BEN TAUB GENERAL HOSPITAL   (United States)

^e HOUSTON METHODIST HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 85170168309     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-1-4160-4044-6.50042-X     Document Type: Chapter

References (410)

1. M. Achtman (1990) Molecular epidemiology of epidemic bacterial meningitis. Rev. Med. Microbiol. 1 29-38.
2. M. Achtman (1991) Clonal properties of meningococci from epidemic meningitis. Trans. R. Soc. Trop. Med. Hyg. 85(Suppl.), 24-31.
3. C.V. Adair, R.L. Gould and J.E. Smadel (1953) Aseptic meningitis, a disease of diverse etiology: Clinical and etiologic studies on 854 cases. Ann. Intern. Med. 39 675-704.
4. R.D. Adams, C.S. Kubik and F.J. Bonner (1948) The clinical and pathological aspects of influenzal meningitis. Arch. Pediatr. 65 354-376.
5. W.G. Adams, K.A. Deaver, S.L. Cochi, et al. (1993) Decline of childhood Haemophilus influenzae type b (Hib) disease in the Hib vaccine era. J. A. M. A. 269 221-226.
6. R. Adegbola, O. Secka, G. Lahai, et al. (2005) Elimination of Haemophilus influenzae type b (Hib) disease from The Gambia after introduction of routine immunization with Hib conjugate vaccine: A prospective study. Lancet. 366 144-150.
7. W.L. Allbritton, G.L. Wiggins and J.C. Feeley (1976) Neonatal listerioses: Distribution of serotypes in relation to age at onset of disease. J. Pediatr. 88 481-483.
8. D.M. Ambrosino, S.H. Landesman, C.C. Gorham, et al. (1986) Passive immunization against disease due to Haemophilus influenzae type b: Concentrations of antibody to capsular polysaccharide in high-risk children. J. Infect. Dis. 153 1-7.
9. American Academy of Pediatrics (2006) Pneumococcal Infections. L.K. Pickering (Eds) 2006 Red Book: Report of the Committee on Infectious Diseases 27th ed. Elk Grove Village, IL: American Academy of Pediatrics 525-537.
10. American Academy of Pediatrics (2006) Haemophilus influenzae infections. L.K. Pickering (Eds) 2006 Red Book: Report of the Committee on Infectious Diseases 27th ed. Elk Grove Village, IL: American Academy of Pediatrics 310-318.
11. American Academy of Pediatrics (2006) Meningococcal infections. L.K. Pickering (Eds) 2006 Red Book: Report of the Committee on Infectious Diseases 27th ed. Elk Grove Village, IL: American Academy of Pediatrics 452-460.
12. American Academy of Pediatrics Committee on Infectious Diseases (1991) Haemophilus influenzae type b conjugate vaccines: Recommendations for immunization of infants and children 2 months of age and older: Update. Pediatrics 88 169-172.
13. American Academy of Pediatrics Committee on Infectious Diseases (2000) Meningococcal disease prevention and control strategies for practice-based physicians (Addendum: Recommendations for college students). Pediatrics 106 1500-1504.
14. American Academy of Pediatrics Committee on Infectious Diseases (2000) Policy Statement: Recommendations for the prevention of pneumococcal infections, including the use of pneumococcal conjugate vaccine (Prevnar), pneumococcal polysaccharide vaccine, and antibiotic prophylaxis. Pediatrics 106 362-366.
15. American Academy of Pediatrics Committee on Infectious Diseases (2005) Prevention and control of meningococcal disease: Recommendations for use of meningococcal vaccines in pediatrics patients. Pediatrics 116 155-157.
16. S. Aminpour, S. Tinling and H. Brodie (2005) Role of tumor necrosis factor-α in sensorineural hearing loss after bacterial meningitis. Otol. Neurotol. 26 602-609.
17. G. Anderson, L. Smithee, M. Rados, et al. (1994) Progress toward elimination of Haemophilus influenzae type b disease among infants and children—United States, 1987-1993. M. M. W. R. Morb. Mortal. Wkly. Rep. 43 144-148.
18. V. Anderson, A. Anderson, K. Grimwood, et al. (2004) Cognitive and executive function 12 years after childhood bacterial meningitis: Effect of acute neurologic complications and age of onset. J. Pediatr. Psychol. 29 67-81.
19. M. Arditi, B.C. Herold and R. Yogev (1989) Cefuroxime treatment failure and Haemophilus influenzae meningitis: Case report and review of the literature. Pediatrics 84 132-135.
20. M. Arditi, E. Mason Jr., J. Bradley, et al. (1998) Three-year multicenter surveillance of pneumococcal meningitis in children: Clinical characteristics, and outcome related to penicillin susceptibility and dexamethasone use. Pediatrics 102 1087-1097.
21. S.C. Aronoff, M.O. Reed, C.A. O'Brien, et al. (1984) Comparison of the efficacy and safety of ceftriaxone to ampicillin/chloramphenicol in the treatment of childhood meningitis. Antimicrob. Agents Chemother. 13 143-151.
22. F. Asensi, M.C. Otero, D. Perez-Tamarit, et al. (1993) Risk/benefit in the treatment of children with imipenem-cilastatin for meningitis caused by penicillin-resistant pneumococcus. J. Chemother. 5 133-134.
23. S. Ashwal, L. Tomasi, S. Schneider, et al. (1992) Bacterial meningitis in children: Pathophysiology and treatment. Neurology 42 739-748.
24. B.I. Asmar and A.S. Dajani (1982) Concurrent pneumococcal disease in two siblings. Am. J. Dis. Child. 136 946-947.
25. C.J. Baker and F.F. Barrett (1972) Transmission of group B streptococci among parturient women and their neonates. J. Pediatr. 83 919-925.
26. R.C. Baker and J.C. Bausher (1986) Meningitis complicating acute bacteremic facial cellulitis. Pediatr. Infect. Dis. 5 421-423.
27. R.C. Balagtas, S. Levin, K.E. Nelson, et al. (1970) Secondary and prolonged fevers in bacterial meningitis. J. Pediatr. 77 957-964.
28. L.N. Baldwin, A. Henderson, P. Thomas, et al. (1993) Acute bacterial meningitis in young adults mistaken for substance abuse. B. M. J. 306 775-776.
29. P. Ballabh, A. Braun and M. Nedergaard (2004) The blood-brain barrier: An overview: Structure, regulation, and clinical implications. Neurobiol. Dis. 16 1-13.
30. J. Band, D.W. Fraser and G. Ajello (1984) Prevention of Hemophilus influenzae type b disease. J. A. M. A. 25 2381-2386.
31. L.J. Baraff, S. Lee and D.L. Schriger (1993) Outcomes of bacterial meningitis in children: A meta-analysis. Pediatr. Infect. Dis. J. 12 389-394.
32. S.J. Barenkamp, D.M. Granoff and R.S. Munson Jr. (1981) Outer-membrane protein subtypes of Haemophilus influenzae type b and spread of disease in day-care centers. J. Infect. Dis. 144 210-217.
33. W.J. Barson, M.A. Miller, M.T. Brady, et al. (1985) Prospective comparative trial of ceftriaxone versus conventional therapy for treatment of bacterial meningitis in children. Pediatr. Infect. Dis. 4 362-368.
34. H. Bashir, M. Laundy and R. Booy (2003) Diagnosis and treatment of bacterial meningitis. Arch. Dis. Child. 88 615-620.
35. E.T. Baumgartner, A. Augustine and R.W. Steele (1983) Bacterial meningitis in older neonates. Am. J. Dis. Child. 137 1052-1054.
36. J.S. Beckman, T.W. Beckman, J. Chen, et al. (1990) Apparent hydroxyl radical production by peroxynitrite: Implications for endothelial injury from nitric oxide and superoxide. Proc. Natl. Acad. Sci. U. S. A. 87 1620-1624.
37. S. Berg, B. Trollfors, S. Hugosson, et al. (2002) Long-term follow-up of children with bacterial meningitis with emphasis on behavioral characteristics. Eur. J. Pediatr. 161 330-336.
38. S.J. Berlow, D.D. Caldarelli, G.J. Matz, et al. (1980) Bacterial meningitis: A prospective investigation. Laryngoscope 90 1445-1452.
39. B.W. Berman, F.H. King Jr., D.S. Rubenstein, et al. (1978) Bacteroides fragilis meningitis in a neonate successfully treated with metronidazole. J. Pediatr. 93 793-795.
40. D. Bermpohl, A. Halle, D. Freyer, et al. (2005) Bacterial programmed cell death of cerebral endothelial cells involves dual death pathways. J. Clin. Invest. 115 1607-1615.
41. L.L. Bernhardt, M.S. Semberkoff and J.J. Rahal Jr. (1981) Deficient cerebrospinal fluid opsonization in experimental Escherichia coli meningitis. Infect. Immun. 32 411-413.
42. Y. Bifrare, J. Kummer, P. Joss, et al. (2005) Brain-derived neurotrophic factor protects against multiple forms of brain injury in bacterial meningitis. J. Infect. Dis. 191 40-45.
43. H.A. Bijlmer (1991) World-wide epidemiology of Haemophilus influenzae meningitis: Industrialized versus non-industrialized countries. Vaccine 9(Suppl.), S5-S9.
44. O. Bilukha and N. Rosenstein National Center for Infectious Disesaes, Centers for Disease Control and Prevention (2005) Prevention and control of meninogococcal disease. Recommendations of the Advisory Committee on Immunization Practices (ACIP). M. M. W. R. Recomm. Rep. 54(RR-7), 1-21.
45. S. Black, H. Shinfield, B. Fireman, et al. (2000) Efficacy, safety and immunogenicity of heptavalent pneumococcal vaccine in children. Pediatr. Infect. Dis. J. 19 187-195.
46. S. Blazer, M. Berant and U. Alon (1983) Bacterial meningitis: Effect of antibiotic treatment on cerebrospinal fluid. Am. J. Clin. Pathol. 80 386-387.
47. V. Bohr, B. Hansen, O. Jessen, et al. (1983) Eight hundred and seventy-five cases of bacterial meningitis. Part I of a three-part series: Clinical data, prognosis, and the role of specialized hospital departments. J. Infect. 7 21-30.
48. T. Bottcher, H. Ren, M. Goiny, et al. (2004) Clindamycin is neuroprotective in experimental Streptococcus pneumoniae meningitis compared with ceftriaxone. J. Neurochem. 91 1450-1460.
49. J.S. Bradley, D.K. Ching and S.E. Phillips (1988) Outpatient therapy of serious pediatric infections with ceftriaxone. Pediatr. Infect. Dis. J. 7 160-164.
50. J.S. Bradley and J.D. Conner (1991) Ceftriaxone failure in meningitis caused by Streptococcus pneumoniae with reduced susceptibility to beta-lactam antibiotics. Pediatr. Infect. Dis. J. 10 871-873.
51. M.T. Brady, S.L. Kaplan and L.H. Taber (1981) Association between persistence of pneumococcal meningitis and dexamethasone administration. J. Pediatr. 99 924-926.
52. C. Brandt, J. Lundgren, N. Frimolt-Moller, et al. (2005) Blocking of leukocyte accumulation in the cerebrospinal fluid augments bacteremia and increased lethality in experimental pneumococcal meningitis. J. Neuroimmunol. 166 126-131.
53. J.S. Braun and E.I. Tuomanen (1999) Molecular mechanisms of brain damage in bacterial meningitis. Adv. Pediatr. Infect. Dis. 14 49-71.
54. R.F. Breiman, J.C. Butler, F.C. Tenover, et al. (1994) Emergence of drug-resistant pneumococcal infections in the United States. J. A. M. A. 271 1831-1835.
55. G. Brenneman, D. Silimperi and J. Ward (1987) Recurrent invasive Haemophilus influenzae type b disease in Alaskan natives. Pediatr. Infect. Dis. J. 6 388-392.
56. J.P. Bryan, H. Rocha, H.R. da Silva, et al. (1985) Comparison of ceftriaxone and ampicillin plus chloramphenicol for the therapy of acute bacterial meningitis. Antimicrob. Agents Chemother. 28 361-368.
57. M. Burroughs, C. Cabellos, S. Prasad, et al. (1992) Bacterial components and the pathophysiology of injury to the blood-brain barrier: Does cell wall add to the effects of endotoxin in gram-negative meningitis? J. Infect. Dis. 165 S82-S85.
58. J.C. Butler, R.F. Breiman and H.B. Lipman (1995) Serotype distribution of Streptococcus pneumoniae infections among preschool children in the United States, 1978-1994: Implications for development of conjugate vaccine. J. Infect. Dis. 171 885-889.
59. D. Cable, G. Overturf and G. Edralin (1983) Concentrations of cefoperazone in cerebrospinal fluid during bacterial meningitis. Antimicrob. Agents Chemother. 23 688-691.
60. J. Carter, B. Neville and C. Newton (2003) Neuro-cognitive impairment following acquired central nervous system infections in childhood: A systematic review. Brain Res. Rev. 43 57-69.
61. Centers for Disease Control (1975) Vestibular reactions to minocycline after meningococcal prophylaxis—New Jersey. M. M. W. R. Morb. Mortal. Wkly. Rep. 24 9-11.
62. Centers for Disease Control (1975) Vestibular reactions to minocycline followup—Georgia, New York, Vermont. M. M. W. R. Morb. Mortal. Wkly. Rep. 24 55-56.
63. Centers for Disease Control (1979) Bacterial meningitis and meningococcemia: United States—1978. M. M. W. R. Morb. Mortal. Wkly. Rep. 28 277-278.
64. Centers for Disease Control (1991) Haemophilus b conjugate vaccines for prevention of Haemophilus influenzae type b disease among infants and children two months of age and older: Recommendations of the Immunization Practices Advisory Committee (ACIP). M. M. W. R. Morb. Mortal. Wkly. Rep. 40 1-7.
65. Centers for Disease Control and Prevention (1997) Control and prevention of meningococcal disease and control and prevention of serogroup C meningococcal disease: Evaluation and management of suspected outbreaks. M. M. W. R. Morb. Mortal. Wkly. Rep. 46(RR-5), 1-21.
66. Centers for Disease Control and Prevention (1998) Progress toward eliminating Haemophilus influenzae type b disease among infants and children—United States, 1987-1997. M. M. W. R. Morb. Mortal. Wkly. Rep. 47 993-998.
67. Centers for Disease Control and Prevention (2000) Recommendations of the Advisory Committee on Immunization Practices: Preventing pneumococcal disease among infants and young children. M. M. W. R. Morb. Mortal. Wkly. Rep. 49(RR-9), 1-35.
68. Centers for Disease Control and Prevention (2002) Progress toward elimination of Haemophilus influenzae type b invasive disease among infants and children—United States 1998-2000. M. M. W. R. Morb. Mortal. Wkly. Rep. 51 234-237.
69. Centers for Disease Control and Prevention (2005) Direct and indirect effects of routine vaccination of children with 7-valent pneumococcal conjugate vaccine on incidence of invasive pneumococcal disease—United States, 1990-2003. M. M. W. R. Morb. Mortal. Wkly. Rep. 54 893-897.
70. Centers for Disease Control and Prevention (2005) Prevention and control of meningococcal disease recommendations of the Advisory Committee on Immunization Practices (ACIP). M. M. W. R. Morb. Mortal. Wkly. Rep. 54(RR-7), 1-17.
71. J.D. Cherry and C.P. Sheenan (1968) Bacteriologic relapse in Haemophilus influenzae meningitis: Inadequate ampicillin therapy. N. Engl. J. Med. 278 1001-1003.
72. F.S. Cole, J.A. Saryan and A.L. Smith (1981) The risk of additional systemic bacterial illness in infants with systemic Streptococcus pneumoniae disease. J. Pediatr. 99 91-94.
73. S.J. Coleman, E.B. Auld, J.D. Connor, et al. (1969) Relapse of Hemophilus influenzae type b meningitis during intravenous therapy with ampicillin. J. Pediatr. 74 781-784.
74. A. Colville, W. Davies, M. Heneghan, et al. (1993) A rare complication of dental treatment: Streptococcus oralis meningitis. Br. Dent. J. 175 133-134.
75. Committee on Infectious Diseases of the American Academy of Pediatrics (1997) Therapy for children with invasive pneumococcal infections. Pediatrics 99 289-299.
76. B.L. Congeni (1984) Comparison of ceftriaxone and traditional therapy of bacterial meningitis. Antimicrob. Agents Chemother. 25 40-44.
77. J.L. Coulehan, R.H. Michaels, C. Hallowell, et al. (1984) Epidemiology of Haemophilus influenzae type b disease among Navajo Indians. Public Health Rep. 99 404-409.
78. R. Dagan, O. Shriker, I. Hazan, et al. (1998) Prospective study to determine clinical relevance of detection of pneumococcal DNA in sera of children by PCR. J. Clin. Microbiol. 36 669-673.
79. A.S. Daoud, A. Batieha, M. Al-Sheyyab, et al. (1999) Lack of effectiveness of dexamethasone in neonatal bacterial meningitis. Eur. J. Pediatr. 158 230-233.
80. R.S. Daum, G.R. Silber, J.S. Kamon, et al. (1982) Evaluation of a commercial latex particle agglutination test for rapid diagnosis of Haemophilus influenzae type b infection. Pediatrics 69 466-471.
81. P.G. Davey, J.K. Cruikshank, I.C. McManus, et al. (1982) Bacterial meningitis—ten years' experience. J. Hyg. 88 383-401.
82. K. Davison and M. Ramsay (2003) The epidemiology of acute meningitis in England and Wales. Arch. Dis. Child. 88 662-664.
83. W.B. Deal and E. Sanders (1969) Efficacy of rifampin in treatment of meningococcal carriers. N. Engl. J. Med. 281 641-645.
84. J. de Gans, D. van de Beek, et al. (2002) Dexamethasone in adults with bacterial meningitis. N. Engl. J. Med. 347 1549-1556.
85. N. Deivanayagam, T.P. Ashaok, K. Nedunchelian, et al. (1993) Evaluation of CSF variables as a diagnostic test for bacterial meningitis. J. Trop. Pediatr. 39 284-287.
86. M.D.A. Del Rio, D.F. Chrane, S. Shelton, et al. (1982) Pharmacokinetics of cefuroxime in infants and children with bacterial meningitis. Antimicrob. Agents Chemother. 22 990-994.
87. M. Del Rio, D. Chrane, S. Shelton, et al. (1983) Ceftriaxone versus ampicillin and chloramphenicol for treatment of bacterial meningitis in children. Lancet 1 1241-1244.
88. J.S. de Morais, R.S. Munford, J.N. Rise, et al. (1974) Epidemic disease due to serogroup L Neisseria meningitidis in São Paulo, Brazil. J. Infect. Dis. 129 568-571.
89. S. Deutch, L. Pedersen, L. Podenphant, et al. (2006) Broad-range real time PCR and DNA sequencing for the diagnosis of bacterial meningitis. Scand. J. Infect. Dis. 38 27-35.
90. I.W. Devoe and J.E. Gilchrist (1975) Pili on meningococci from primary cultures of nasopharyngeal carriers and cerebrospinal fluid of infants with acute disease. J. Exp. Med. 141 297-305.
91. A. Diab, J. Zhu, L. Lindquist, et al. (1997) Haemophilus influenzae and Streptococcus pneumoniae induce different intracerebral mRNA cytokine patterns during the course of experimental bacterial meningitis. Clin. Exp. Immunol. 109 233-241.
92. G. Dicuonzo, G. Lorino, D. Lilli, et al. (1999) Use of oligoprobes on amplified DNA in the diagnosis of bacterial meningitis. Eur. J. Clin. Microbiol. Infect. Dis. 18 352-357.
93. C.A. Dinarello and J.W. Mier (1987) Lymphokines. N. Engl. J. Med. 317 940-945.
94. M.C. Di Pentima, E.O. Mason Jr. and S.L. Kaplan (1998) In vitro antibiotic synergy against Flavobacterium meningosepticum: Implications for therapeutic options. Clin. Infect. Dis. 26 1169-1176.
95. P.R. Dodge, H. Davis, R.D. Feigin, et al. (1984) Prospective evaluation of hearing impairment as a sequela of acute bacterial meningitis. N. Engl. J. Med. 311 869-874.
96. P.R. Dodge and M.N. Swartz (1965) Bacterial meningitis: A review of selected aspects, II: Special neurologic problems, postmeningitic complications and clinicopathological correlations. N. Engl. J. Med. 272 1003-1010.
97. M. du Plessis, A.M. Smith and K.P. Klugman (1998) Rapid detection of penicillin-resistant Streptococcus pneumoniae in cerebrospinal fluid by a seminested-PCR strategy. J. Clin. Microbiol. 36 453-457.
98. K.M. Edwards, R. Alford, H. Gewurz, et al. (1983) Recurrent bacterial infections associated with C3 nephritic factor and hypocomplementemia. N. Engl. J. Med. 308 1138-1141.
99. T.C. Eickhoff (1971) In-vitro and in-vivo studies of resistance to rifampin in meningococci. J. Infect. Dis. 123 414-420.
100. R.T. Ellison III, P.F. Kohler, J.G. Curd, et al. (1983) Prevalence of congenital or acquired complement deficiency in patients with sporadic meningococcal disease. N. Engl. J. Med. 308 913-916.
101. A.J. Eraklis, S.V. Kevy, L.K. Diamond, et al. (1967) Hazard of overwhelming infection after splenectomy in childhood. N. Engl. J. Med. 276 1225-1229.
102. J.D. Ernst, J.M. Decazes and M.A. Sande (1983) Experimental pneumococcal meningitis: The role of leukocytes in pathogenesis. Infect. Immun. 41 275-279.
103. J.D. Ernst, K.T. Hartiala, I.M. Goldstein, et al. (1984) Complement (C5)-derived chemotactic activity accounts for accumulation of polymorphonuclear leukocytes in cerebrospinal fluid of rabbits with pneumococcal meningitis. Infect. Immun. 46 81-86.
104. R. Feigin (2004) Use of corticosteroids in bacterial meningitis. Pediatr. Infect. Dis. J. 23 355-357.
105. R.D. Feigin (1987) Bacterial meningitis beyond the newborn period. R.D. Feigin, J.D. Cherry (Eds) Textbook of Pediatric Infectious Diseases 2nd ed. Philadelphia: W. B. Saunders 439-465.
106. R.D. Feigin, C.J. Baker, L.A. Herwaldt, et al. (1982) Epidemic meningococcal disease in an elementary-school classroom. N. Engl. J. Med. 307 1255-1257.
107. R.D. Feigin and P.R. Dodge (1976) Bacterial meningitis: Newer concepts of pathophysiology and neurologic sequelae. Pediatr. Clin. North Am. 23 541-556.
108. Feigin, R. D., and Dodge, P. R.: Personal experience: Unpublished data for prospective studies of bacterial meningitis, 1974-1979.
109. Feigin, R. D., and Dodge, P. R.: Personal communications, 1974-1991.
110. Feigin, R. D., and Dodge, P. R.: Personal data.
111. R.D. Feigin and S. Kaplan (1977) Inappropriate secretion of antidiuretic hormone (ADH) in children with bacterial meningitis. Am. J. Clin. Nutr. 30 1482-1484.
112. R.D. Feigin, G.H. McCracken and J.O. Klein (1992) Diagnosis and management of meningitis. Pediatr. Infect. Dis. J. 11 785-814.
113. R.D. Feigin and P.G. Shackelford (1973) Sequential lumbar puncture as a diagnostic aid in aseptic meningitis. N. Engl. J. Med. 289 571-574.
114. R.D. Feigin and W.T. Shearer (1975) Opportunistic infection in children, Part I: In the compromised host. J. Pediatr. 87 507-514.
115. R.D. Feigin and W.T. Shearer (1975) Opportunistic infection in children, Part II: In the compromised host. J. Pediatr. 87 677-694.
116. R.D. Feigin, B.W. Stechenberg, M.J. Chang, et al. (1976) Prospective evaluation of treatment of Hemophilus influenzae meningitis. J. Pediatr. 88 773-775.
117. R.D. Feigin, M. Wong, P.G. Shackelford, et al. (1976) Countercurrent immunoelectrophoresis of urine as well as CSF and blood for the diagnosis of bacterial meningitis. J. Pediatr. 89 773-774.
118. H.M. Feldman and R.H. Michaels (1988) Academic achievement in children 10 to 12 years after Haemophilus influenzae meningitis. Pediatrics 81 339-344.
119. W.E. Feldman (1976) Concentrations of bacteria in cerebrospinal fluid of patients with bacterial meningitis. J. Pediatr. 88 549-552.
120. W.E. Feldman, C.B. Ginsburg, G.H. McCracken, et al. (1982) Relation of concentrations of Haemophilus influenzae type b in cerebrospinal fluid to late sequelae of patients with meningitis. J. Pediatr. 100 209-218.
121. W.E. Feldman, S. Moffitt and N.S. Manning (1982) Penetration of cefoxitin into cerebrospinal fluid of infants and children with bacterial meningitis. Antimicrob. Agents Chemother. 21 468-471.
122. W.E. Feldman and J. Schwartz (1983) Haemophilus influenzae type b brain abscess complicating meningitis: Case report. Pediatrics 72 473-475.
123. M. Finland and M.W. Barnes (1977) Acute bacterial meningitis at Boston City Hospital during 12 selected years, 1935-1972. J. Infect. Dis. 136 400-415.
124. F.O. Finlay, H. Witherow and P.T. Rudd (1995) Latex agglutination testing in bacterial meningitis. Arch. Dis. Child. 73 160-161.
125. A.E. Fiore, J.F. Moroney, M.M. Farley, et al. (2000) Clinical outcomes of meningitis caused by Streptococcus pneumoniae in the era of antibiotic resistance. Clin. Infect. Dis. 30 71-77.
126. G.W. Fischer, R.W. Brenz, E.R. Alden, et al. (1975) Lumbar puncture and meningitis. Am. J. Dis. Child. 129 590-592.
127. P. Forgacs, C.A. Geyer and S.R. Freidberg (2001) Characterization of chemical meningitis after neurological surgery. Clin. Infect. Dis. 32 179-185.
128. R.A. Franciosi, J.D. Knostman and R.A. Zimmerman (1973) Group B streptococcal neonatal and infant infections. J. Pediatr. 82 707-718.
129. C.E. Frasch, B.S. Pepple, T.R. Cate, et al. (1982) Immunogenicity and clinical evaluation of group B Neisseria meningitidis outer membrane protein vaccines. L. Weinstein, B.N. Fields (Eds) Seminar in Infectious Diseases. Vol. 4. Bacterial Vaccines New York: Thieme-Stratton 263-267.
130. D.W. Fraser, C.P. Darby, R.E. Koehler, et al. (1973) Risk factors in bacterial meningitis: Charleston County, South Carolina. J. Infect. Dis. 127 271-277.
131. D.W. Fraser, C.C. Geil and R.A. Feldman (1974) Bacterial meningitis in Bernalilla County, New Mexico: A comparison with three other American populations. Am. J. Epidemiol. 100 29-34.
132. D.W. Fraser, C.E. Henke and R.A. Feldman (1973) Changing patterns of bacterial meningitis in Olmstead County, Minnesota, 1935-1970. J. Infect. Dis. 128 300-307.
133. D.W. Fraser, J.E. Mitchell, L.P. Silverman, et al. (1975) Undiagnosed bacterial meningitis in Vermont children. Ann. J. Epidemiol. 102 394-399.
134. K. Frei, D. Piani, H.W. Pfister, et al. (1993) Immune-mediated injury in bacterial meningitis. Int. Rev. Exp. Pathol. 34 183-192.
135. L.D. Frenkel, the Multicenter Ceftriaxone Pediatric Study Group (1988) Once-daily administration of ceftriaxone for the treatment of selected serious bacterial infections in children. Pediatrics 82 486-491.
136. I.R. Friedland and K.P. Klugman (1992) Antibiotic-resistant pneumococcal disease in South African children. Am. J. Dis. Child. 146 920-923.
137. I.R. Friedland, M. Paris, S. Ehrett, et al. (1993) Evaluation of antimicrobial regimens for treatment of experimental penicillin- and cephalosporin-resistant pneumococcal meningitis. Antimicrob. Agents Chemother. 37 1630-1636.
138. I.R. Friedland, M. Paris, S. Shelton, et al. (1994) Time-kill studies of antibiotic combinations against penicillin-resistant and -susceptible Streptococcus pneumoniae. J. Antimicrob. Chemother. 34 231-237.
139. I.R. Friedland, S. Shelton, M. Paris, et al. (1993) Dilemmas in diagnosis and management of cephalosporin-resistant Streptococcus pneumoniae meningitis. Pediatr. Infect. Dis. J. 12 196-200.
140. M. Gado, J. Axley, D.B. Appleton, et al. (1974) Angiography in the acute and post-treatment phases of Haemophilus influenzae meningitis. Radiology 110 439-444.
141. J.L. Gaillard, G. Abadie, J. Cheron, et al. (1994) Concentrations of ceftriaxone in cerebrospinal fluid of children with meningitis receiving dexamethasone therapy. Antimicrob. Agents Chemother. 38 1209-1210.
142. H. Garcia, S.L. Kaplan and R.D. Feigin (1981) Cerebrospinal fluid concentration of arginine vasopressin in children with bacterial meningitis. J. Pediatr. 98 67-70.
143. P. Garred, T.E. Michaelsen, G. Bjune, et al. (1993) A low serum concentration of mannan-binding protein is not associated with serogroup B or C meningococcal disease. Scand. J. Immunol. 37 468-470.
144. N. Gary, N. Powers and J.K. Todd (1989) Clinical identification and comparative prognosis of high-risk patients with Haemophilus influenzae meningitis. Am. J. Dis. Child. 143 307-311.
145. P.J. Geiseler and K.E. Nelson (1982) Bacterial meningitis without clinical signs of meningeal irritation. South. Med. J. 75 448-450.
146. P.J. Geiseler, K.E. Nelson and S. Levin (1980) Community-acquired purulent meningitis: A review of 1,316 cases during the antibiotic era, 1954-1976. Rev. Infect. Dis. 2 725-744.
147. J. Gerber, T. Bottcher, M. Hahn, et al. (2004) Increased mortality and spatial memory deficits in TNF-alpha-deficient mice in ceftriaxone-treated experimental pneumococcal meningitis. Neurobiol Dis. 16 133-138.
148. J. Gerber, M. Lotz, S. Ebert, et al. (2005) Melatonin is neuroprotective in experimental Streptococcus pneumoniae meningitis. J. Infect. Dis. 191 783-790.
149. J. Gerber, K. Pohl, V. Sander, et al. (2003) Rifampin followed by ceftriaxone for experimental meningitis decreases lipoteichoic acid concentrations in cerebrospinal fluid and reduces neuronal damage in comparison to ceftriaxone alone. Antimicrob. Agents Chemother. 47 1313-1317.
150. L.U. Gerdes, P.E. Jorgensen, E. Nexo, et al. (1998) C-reactive protein and bacterial meningitis: A meta-analysis. Scand. J. Clin. Lab. Invest. 58 383-393.
151. B. Gessner, A. Sutanto, M. Linehan, et al. (2005) Incidences of vaccine-preventable Haemophilus influenzae type b pneumonia and meningitis in Indonesian children: Hamlet-randomised vaccine-probe trial. Lancet 365 43-52.
152. C. Giampaolo, W.M. Scheld, J. Boyd, et al. (1982) Leukocyte and bacterial interrelationships in experimental meningitis. Ann. Neurol. 9 328-333.
153. F. Gigliotti, D. Lee, R.A. Insel, et al. (1987) IgG penetration into the cerebrospinal fluid in a rabbit model of meningitis. J. Infect. Dis. 156 394-398.
154. G. Gilbert (1991) Epidemiology of Haemophilus influenzae type b disease in Australia and New Zealand. Vaccine 9(Suppl.), S10-S13.
155. D.L. Gilday (1974) Various radionuclide patterns of cerebral inflammation in infants and children. A. J. R. Am. J. Roentgenol. 120 247-253.
156. C.M. Ginsburg, G.H. McCracken Jr. and J.J. Parke (1977) Haemophilus influenzae type b disease in a day-care center. Pediatr. Res. 11 435.
157. N.I. Girgis, A.H. Abu El Ella, Z. Farid, et al. (1988) Intramuscular ceftriaxone versus ampicillin-chloramphenicol in childhood bacterial meningitis. Scand. J. Infect. Dis. 20 613-617.
158. N.I. Girgis, Z. Farid, I.A. Mikhail, et al. (1989) Dexamethasone treatment for bacterial meningitis in children and adults. Pediatr. Infect. Dis. J. 5 210-215.
159. D. Gitlin (1955) Pathogenesis of subdural collections of fluid. Pediatrics 16 345-351.
160. L.B. Givner, E.O. Mason Jr., W.J. Barson, et al. (2000) Pneumococcal facial cellulitis in children. Pediatrics 106 e61.
161. R. Gold (1983) Bacterial meningitis—1982. Am. J. Med. 75 98-101.
162. R. Gold (1999) Epidemiology of bacterial meningitis. Infect. Dis. Clin. N. Am. 13 515-525.
163. D. Gradgirard and S. Leib (2006) Strategies to prevent neuronal damage in pediatric bacterial meningitis. Curr. Opin. Pediatr. 18 112-118.
164. S.M. Green, S.G. Rothrock, K.J. Clem, et al. (1993) Can seizures be the sole manifestation of meningitis in febrile children? Pediatrics 92 527-534.
165. S. Greenfield and H.A. Feldman (1967) Familial carriers and meningococcal meningitis. N. Engl. J. Med. 277 487-502.
166. K. Grimwood, V.A. Anderson, L. Bond, et al. (1995) Adverse outcomes of bacterial meningitis in school-age survivors. Pediatrics 95 646-656.
167. H.M. Grubbauer, H.J. Dornbusch, P. Dittrich, et al. (1990) Ceftriaxone monotherapy for bacterial meningitis in children. Chemotherapy 36 441-447.
168. M. Guibourdenche, D.A. Caugant, V. Hervé, et al. (1994) Characteristics of serogroup A Neisseria meningitidis strains isolated in the Central African Republic in February 1992. Eur. J. Clin. Microbiol. Infect. Dis. 13 174-177.
169. J.-M. Gulian, V. Gonard, C. Dalmasso, et al. (1987) Bilirubin displacement by ceftriaxone in neonates: Evaluation by determination of “free” bilirubin and erythrocyte-bound bilirubin. J. Antimicrob. Chemother. 19 823-829.
170. D.W. Gump (1981) Vancomycin for treatment of bacterial meningitis. Rev. Infect. Dis. 3 S289-S292.
171. R.B. Guttler, G.W. Counts, C.K. Avent, et al. (1971) Effect of rifampin and minocycline on meningococcal carrier rates. J. Infect. Dis. 124 199-205.
172. R.T. Haimanot, D.A. Caugant, D. Fekadu, et al. (1990) Characteristics of serogroup A Neisseria meningitidis responsible for an epidemic in Ethiopia, 1988-89. Scand. J. Infect. Dis. 22 171-174.
173. B.D. Hall (1968) Failure of ampicillin in meningitis. Lancet 1 1033.
174. K.C. Haltalin and J.B. Smith (1971) Reevaluation of ampicillin therapy for Haemophilus influenzae meningitis: An appraisal based on a review of cases of persistent or recurrent infection. Am. J. Dis. Child. 122 328-336.
175. D. Hansman and G.A. Andrews (1967) A resistant pneumococcus. Lancet 2 264-265.
176. D. Hansman, J. Hanna and F. Morey (1986) High prevalence of invasive Haemophilus influenzae disease in central Australia, 1986. Lancet 2 927.
177. E.H. Hanson, D.M. Niemeyer, L. Folio, et al. (2004) Potential use of microarray technology for rapid identification of central nervous system pathogens. Milit. Med. 169 594-599.
178. L. Harrison (2006) Prospects for vaccine prevention of meningococcal infection. Clin. Microbiol. Rev. 19 142-164.
179. L.H. Harrison, D.M. Dwyer, C.T. Maples, et al. (1999) Risk of meningococcal infection in college students. J. A. M. A. 281 1906-1910.
180. D. Hatch, G.D. Overturf, A. Kovacs, et al. (1986) Treatment of bacterial meningitis with ceftazidime. Pediatr. Infect. Dis. 5 416-420.
181. P.L. Haven, K.J. Wendelgerger, G.M. Hoffman, et al. (1989) Corticosteroids as adjunctive therapy in bacterial meningitis. Am. J. Dis. Child. 143 1051-1055.
182. C. Healy and C. Baker (2005) The future of meningococcal vaccines. Pediatr. Infect. Dis. J. 24 175-176.
183. K. Hirakawa, M. Kurokawa, K. Yajin, et al. (1983) Recurrent meningitis due to a congenital fistula in the stapedial footplate. Arch. Otolaryngol. 109 697-700.
184. O. Hoffmann, N. Keilwerth, M. Bille, et al. (2002) Triptans reduce the inflammatory response in bacterial meningitis. J. Cereb. Blood Flow. Metab. 22 988-996.
185. K. Hogasen, T. Michaelsen, O.J. Mellbye, et al. (1993) Low prevalence of complement deficiencies among patients with meningococcal disease in Norway. Scand. J. Immunol. 37 487-489.
186. S.J. Holmes, A.H. Lucas, M.T. Osterholm, et al. (1991) Immunoglobulin deficiency and idiotype expression in children developing Haemophilus influenzae type b disease after vaccination with conjugate vaccine. The Collaborative Study Group. J. A. M. A. 266 1960-1965.
187. D.L. Ingram, P. Anderson and D.H. Smith (1972) Counter-current immunoelectrophoresis in the diagnosis of systemic disease caused by Hemophilus influenzae, type b. J. Pediatr. 81 1156-1159.
188. D.L. Ingram, A.W. Pearson and A.R. Occhiuti (1983) Detection of bacterial antigens in body fluids with the Wellcogen Haemophilus influenzae b, Streptococcus pneumoniae, and Neisseria meningitidis (ACYW135) latex agglutination tests. J. Clin. Microbiol. 18 1119-1121.
189. L.A. Jackson, A. Schuchat, M.W. Reeves, et al. (1995) Serogroup C meningococcal outbreaks in the United States: An emerging threat. J. A. M. A. 273 383-389.
190. T. Jadavji, W.D. Biggar, R. Gold, et al. (1985) Sequelae of acute bacterial meningitis in children treated for seven days. Pediatrics 78 21-25.
191. D.L. Jaye and K.B. Waites (1997) Clinical applications of C-reactive protein in pediatrics. Pediatr. Infect. Dis. J. 16 735-746.
192. J.L. Kadurugamuwa, B. Hengstler and O. Zak (1987) Effects of antiinflammatory drugs on arachidonic-acid metabolites and cerebrospinal fluid (CSF) proteins during infectious pneumococcal meningitis in rabbits. Pediatr. Infect. Dis. 6(Suppl.), 1153-1154.
193. J.L. Kadurugamuwa, B. Hengstler and O. Zak (1989) Cerebrospinal fluid protein profile in experimental pneumococcal meningitis and its alteration by ampicillin and anti-inflammatory agents. J. Infect. Dis. 159 26-34.
194. W.M. Kaene, W.P. Postic, L.D. Rowe, et al. (1979) Meningitis and hearing loss in children. Otolaryngology 105 39-44.
195. S.L. Kaplan (1999) Clinical presentations, diagnosis, and prognostic factors of bacterial meningitis. Infect. Dis. Clin. N. Am. 13 579-594.
196. S.L. Kaplan, F.I. Catlin, T. Weaver, et al. (1984) Onset of hearing loss in children with bacterial meningitis. Pediatrics 73 575-578.
197. S.L. Kaplan and R.D. Feigin (1978) The syndrome of inappropriate secretion of antidiuretic hormone in children with bacterial meningitis. J. Pediatr. 92 758-761.
198. S.L. Kaplan and R.D. Feigin (1980) Rapid identification of the invading microorganism. Pediatr. Clin. North Am. 27 783-803.
199. S.L. Kaplan and M.A. Fishman (1987) Supportive therapy for bacterial meningitis. Pediatr. Infect. Dis. J. 6 670-677.
200. S.L. Kaplan, J. Goddard, M. VanKleeck, et al. (1981) Ataxia and deafness in children due to bacterial meningitis. Pediatrics 68 8-13.
201. S.L. Kaplan and E.O. Mason Jr. (1998) Management of infections due to antibiotic-resistant Streptococcus pneumoniae. Clin. Microbiol. Rev. 11 628-644.
202. S.L. Kaplan, E.O. Mason Jr., S.K. Mason, et al. (1984) Prospective com-parative trial of moxalactam versus ampicillin or chloramphenicol for treatment of Haemophilus influenzae type b meningitis. J. Pediatr. 104 447-453.
203. S.L. Kaplan, E.O. Mason Jr., E.R. Wald, et al. (2002) Six-year multicenter surveillance of invasive pneumococcal infections in children. Pediatr. Infect. Dis. J. 21 141-147.
204. S.L. Kaplan, E.O. Smith, C. Wills, et al. (1986) Association between preadmission oral antibiotic therapy and cerebrospinal fluid findings and sequelae caused by Haemophilus influenzae type b meningitis. Pediatr. Infect. Dis. 5 626-632.
205. J. Kellner, D. Scheifele, S. Halperin, et al. (2002) Outcome of penicillin-nonsusceptible Streptococcus pneumoniae meningitis: A nested case-control study. Pediatr. Infect. Dis. J. 21 903-909.
206. W.A. Kennedy, M.J. Hoyt and G.H. McCracken (1991) The role of corticosteroids in children with pneumococcal meningitis. Am. J. Dis. Child. 145 1374-1478.
207. R.E. Kessler (2001) Cefepime microbiologic profile and update. Pediatr. Infect. Dis. J. 20 331-336.
208. M. Kilpatrick, N. Girgis, Z. Farid, et al. (1991) Aztreonam for treating meningitis caused by gram-negative rods. Scand. J. Infect. Dis. 23 125-126.
209. Y.O. Kim, J.S. Kang, M.H. Youm, et al. (2003) Diagnostic capability of CSF ferritin in children with meningitis. Pediatr. Neurol. 28 271-276.
210. Y.S. Kim and M.G. Tauber (1996) Neurotoxicity of glia activated by gram-positive bacterial products depends on nitric oxide production. Infect. Immun. 64 3148-3153.
211. P.E. Klass and J.O. Klein (1992) Therapy of bacterial sepsis, meningitis and otitis media in infants and children: 1992 poll of directors of programs in pediatric infectious diseases. Pediatr. Infect. Dis. J. 11 702-705.
212. M.D. Kleiman, G.A. Weinberg, J.K. Reynolds, et al. (1993) Meningitis with beta-lactam-resistant Streptococcus pneumoniae: The need for early repeat lumbar puncture. Pediatr. Infect. Dis. J. 12 782-784.
213. J.O. Klein, R.D. Feigin and G.H. McCracken Jr. (1986) Report of the Task Force on Diagnosis and Management of Meningitis. Pediatrics 78 S959-S982.
214. M. Klein, U. Koedel, H. Pfister and S. Kastenbauer (2003) Meningitis-associated hearing loss: Protection by adjunctive antioxidant therapy. Ann. Neurol. 54 451-458.
215. M.W. Kline and S.L. Kaplan (1988) Computed tomography in bacterial meningitis of childhood. Pediatr. Infect. Dis. J. 7 855-857.
216. K.P. Klugman and R. Dagan The Meropenem Meningitis Study Group (1995) Randomized comparison of meropenem with cefotaxime for treatment of bacterial meningitis. Antimicrob. Agents Chemother. 39 1140-1146.
217. K.P. Klugman, I.R. Friedland and J.S. Bradley (1995) Bactericidal activity against cephalosporin-resistant Streptococcus pneumoniae in cerebrospinal fluid of children with acute bacterial meningitis. Antimicrob. Agents Chemother. 39 1988-1992.
218. U. Koedel, A. Bernatowicz, R. Paul, et al. (1995) Experimental pneumococcal meningitis: Cerebrovascular alterations, brain edema, and meningeal inflammation are linked to the production of nitric oxide. Ann. Neurol. 37 313-323.
219. U. Koedel, W. Scheld and H. Pfister (2002) Pathogenesis and pathophysiology of pneumococcal meningitis. Lancet Infect. Dis. 2 721-736.
220. R.N. Komorowski, S.G. Farmer and L.L. Hause (1978) Cerebrospinal fluid lactic acid in diagnosis of meningitis. J. Clin. Microbiol. 8 89-92.
221. I. Koomen, D. Grobbee, J. Roord, et al. (2003) Hearing loss at school age in survivors of bacterial meningitis: Assessment, incidence and prediction. Pediatrics 112 1049-1053.
222. I. Koomen, A. van Furth, M. Kraak, et al. (2004) Neuropsychology of academic and behavioral limiations in school-age survivors of bacterial meningitis. Dev. Med. Child Neurol. 46 724-732.
223. R.F. Kornelisse, C.E. Hack, H.F. Savelkoul, et al. (1997) Intrathecal production of interleukin-12 and gamma interferon in patients with bacterial meningitis. Infect. Immun. 65 877-881.
224. P. Kotilainen, J. Jalava, O. Meurman, et al. (1998) Diagnosis of meningococcal meningitis by broad-range bacterial PCR with cerebrospinal fluid. J. Clin. Microbiol. 36 2205-2209.
225. M. Kyaw, R. Lynfield, W. Schaffner, et al. (2006) Effect of introduction of the pneumococcal conjugate vaccine on drug-resistant Streptococcus pneumoniae. N. Engl. J. Med. 354 1455-1463.
226. L.J. LaScolea Jr. and D. Dryja (1984) Quantitation of bacteria in cerebrospinal fluid and blood of children with meningitis and its diagnostic significance. J. Clin. Microbiol. 19 187-190.
227. M.H. Lebel, B.J. Freij, G.A. Syrogiannopoulos, et al. (1988) Dexamethasone therapy for bacterial meningitis: Results of two double-blind, placebo-controlled trials. N. Engl. J. Med. 319 964-971.
228. M.H. Lebel, M.J. Hoyt and G.H. McCracken (1989) Comparative efficacy of ceftriaxone and cefuroxime for treatment of bacterial meningitis. J. Pediatr. 114 1049-1054.
229. M.H. Lebel and G.H. McCracken Jr. (1988) Aztreonam: Review of the clinical experience and potential uses in pediatrics. Pediatr. Infect. Dis. J. 7 331-339.
230. M.H. Lebel and G.H. McCracken Jr. (1989) Delayed cerebrospinal fluid sterilization and adverse outcome of bacterial meningitis in infants and children. Pediatrics 83 161-167.
231. J.M. Leedom, D. Ivler, A.W. Mathies, et al. (1966) The problem of sulfadiazine-resistant meningococci. Antimicrob. Agents Chemother. 6 281-292.
232. R.J. Leggiadro and J.A. Winkelstein (1987) Prevalence of complement deficiencies in children with systemic meningococcal disease. Pediatr. Infect. Dis. J. 6 75-76.
233. S. Leib, C. Heimgartner, Y. Bifrare, et al. (2003) Dexamethasone aggravates hippocampal apoptosis and learning deficiency in pneumococcal meningitis in infant rats. Pediatr. Res. 54 353-357.
234. S.L. Leib and M.D. Tauber (1999) Pathogenesis of bacterial meningitis. Infect. Dis. Clin. N. Am. 13 527-548.
235. J. Leimkugel, A. Adams Forgor, S. Gagneux, et al. (2005) An outbreak of serotype 1 Streptococcus pneumoniae meningitis in northern Ghana with features that are characteristic of Neisseria meningitides meningitis epidemics. J. Infect. Dis. 192 192-199.
236. S.J. Lerman (1982) Systemic Hemophilus influenzae infection: A study of risk factors. Clin. Pediatr. 21 360-364.
237. O.S. Levine, M. Farley, L.E. Harrison, et al. (1999) Risk factors for invasive pneumococcal disease in children: A population-based case-control study in North America. Pediatrics 103 e28.
238. E.P. Liebman, M.L. Ronis, J.H. Loyrinic, et al. (1969) Hearing improvement following meningitis deafness. Arch. Otolaryngol. 90 470-473.
239. D. Lim, A. Gerurz, T.F. Lint, et al. (1976) Absence of the sixth component of complement in a patient with repeated episodes of meningococcal meningitis. J. Pediatr. 89 42-47.
240. T.Y. Lin, D.F. Chrane, J.D. Nelson, et al. (1985) Seven days of ceftriaxone therapy is as effective as ten days' treatment for bacterial meningitis. J. A. M. A. 253 3559-3563.
241. J. Lindsay (1973) Profound childhood deafness: Inner ear pathology. Ann. Otol. Rhinol. Laryngol. 82(Suppl. 5), 88-102.
242. G.A. Losonsky, M. Santosham, V.M. Sehgal, et al. (1984) Haemophilus influenzae disease in the White Mountain Apaches: Molecular epidemiology of a high risk population. Pediatr. Infect. Dis. 3 539-547.
243. J.M. MacLennan, F. Shackley, P.T. Heath, et al. (2000) Safety, immunogenicity, and induction of immunologic memory by a serogroup C meningococcal conjugate vaccine in infants: A randomized controlled trial. J. A. M. A. 283 2795-2801.
244. E.T. Madagame, P.L. Havens, J.M. Bresnahan, et al. (1995) Survival and functional outcome of children requiring mechanical ventilation during therapy for acute bacterial meningitis. Crit. Care Med. 23 1279-1283.
245. M.M. Mariscalco (2006) Innate immunity in critical care. Semin. Pediatr. Infect. Dis. 17 25-35.
246. W.A. Marks, H.R. Stutman, M.I. Marks, et al. (1986) Cefuroxime versus ampicillin plus chloramphenicol in childhood bacterial meningitis: A multicenter randomized controlled trial. J. Pediatr. 109 123-130.
247. S. Maxson, M.J. Lewno and G.E. Schutze (1994) Clinical usefulness of cerebrospinal fluid bacterial antigen studies. J. Pediatr. 125 235-238.
248. G.H. McCracken, L.D. Sarff, M.P. Glode, et al. (1974) Relation between Escherichia coli K1 capsular polysaccharide antigen and clinical outcome in neonatal meningitis. Lancet 2 246-250.
249. G.J. McCracken Jr. and M.H. Lebel (1989) Dexamethasone therapy for bacterial meningitis in infants and children. Am. J. Dis. Child. 143 287-289.
250. D. McIntosh, J. Brown, R. Hanson, et al. (1993) Torticollis and bacterial meningitis. Pediatr. Infect. Dis. J. 12 160-161.
251. P.B. McIntyre, C.S. Berkey, S.M. King, et al. (1997) Dexamethasone as adjunctive therapy in bacterial meningitis. J. A. M. A. 278 925-931.
252. M.E. Melish, A.J. Nelson, T.E. Martin, et al. (1976) Epidemic spread of Hemophilus influenzae type b disease in a day care center. Pediatr. Res. 10 348.
253. Meningococcal Meningitis (2003) Wkly. Epidemiol. Rec. 78 292-296.
254. J. Mertsola, W.A. Kennedy, D. Waagner, et al. (1991) Endotoxin concentrations in cerebrospinal fluid correlate with clinical severity and neurologic outcome of Haemophilus influenzae type b meningitis. Am. J. Dis. Child. 145 1099-1103.
255. O.H. Meurman, K. Irjala, J. Suonpaa, et al. (1979) A new method for the identification of cerebrospinal fluid leakage. Acta Otolaryngol. 87 366-369.
256. H.R. Michie, K.R. Manogue, D.R. Spriggs, et al. (1988) Detection of circulation tumor necrosis factor after endotoxin administration. N. Engl. J. Med. 318 1481-1486.
257. L. Mitchell, S. Smith, J. Braun, et al. (2004) Dual phases of apoptosis in pneumococcal meningitis. J. Infect. Dis. 190 2039-2046.
258. J. Modai, D. Vittecoq, J.M. Decazes, et al. (1983) Penetration of ceftazidime into cerebrospinal fluid of patients with bacterial meningitis. Antimicrob. Agents Chemother. 24 126-128.
259. R.C. Moellering (1984) Pharmacokinetics of vancomycin. J. Antimicrob. Chemother. 14 43-52.
260. P.S. Moore, L.H. Harrison, E.E. Telzak, et al. (1988) Group A meningococcal carriage in travelers returning from Saudi Arabia. J. A. M. A. 260 2686-2689.
261. P.S. Moore, M.W. Reeves, B. Schwartz, et al. (1989) Intercontinental spread of an epidemic group A Neisseria meningitidis strain. Lancet 2 260-263.
262. E.A. Mothershed, C.T. Sacchi, A.M. Whitney, et al. (2004) Use of real-time PCR to resolve slide agglutination discrepancies in serogroup identification of Neisseria meningitidis. J. Clin. Microbiol. 42 320-328.
263. A. Moura, A. Pablos-Mendez, M. Layton and D. Weiss (2003) Epidemiology of meningococcal disease, New York City, 1989-2000. Emerg. Infect. Dis. 9 355-361.
264. E.R. Moxon, A.L. Smith, D.R. Averill, et al. (1974) Hemophilus influenzae meningitis in infant rats after intranasal inoculation. J. Infect. Dis. 129 154-162.
265. D.T. Mullaney and J.F. John (1983) Cefotaxime therapy: Evaluation of its effect on bacterial meningitis, CSF drug levels, and bactericidal activity. Arch. Intern. Med. 143 1705-1708.
266. R.J. Mumford, Z.J.S. deVasconelas, C.J. Phillips, et al. (1974) Eradication of carriage of Neisseria meningitidis in families: A study in Brazil. J. Infect. Dis. 129 644-649.
267. O. Munoz, L. Benitez-Diaz, M.C. Martinez, et al. (1983) Hearing loss after Hemophilus influenzae meningitis: Follow-up study with auditory brainstem potentials. Ann. Otol. Rhinol. Laryngol. 92 272-275.
268. T.V. Murphy, P. Pastor, F. Medley, et al. (1993) Decreased Haemophilus colonization in children vaccinated with Haemophilus influenzae type b conjugate vaccine. J. Pediatr. 122 517-523.
269. M.M. Mustafa, M.H. Lebel, O. Ramilo, et al. (1989) Correlation of interleukin 1β and cachectin concentrations in cerebrospinal fluid and outcome from bacterial meningitis. J. Pediatr. 115 208-213.
270. M.M. Mustafa, O. Ramilo, J. Mertsola, et al. (1989) Modulation of inflammation and cachectin activity in relation to treatment of experimental Haemophilus influenzae type b meningitis. J. Infect. Dis. 160 818-825.
271. M.M. Mustafa, O. Ramilo, X. Saez-Llorens, et al. (1990) Cerebrospinal fluid prostaglandins, interleukin 1β, and tumor necrosis factor in bacterial meningitis: Clinical and laboratory correlations in placebo and dexamethasone-treated patients. Am. J. Dis. Child. 144 883-887.
272. J.B. Nadol Jr. (1978) Hearing loss as a sequela of meningitis. Laryngoscope 88 739-755.
273. M. Nagata, T. Hara, T. Aoki, et al. (1989) Inherited deficiency of ninth component of complement: An increased risk of meningococcal meningitis. J. Pediatr. 114 260-264.
274. S. Naraqui, G.P. Kirkpatrick and S. Kabins (1974) Relapsing pneumococcal meningitis: Isolation of an organism with decreased susceptibility to penicillin G. J. Pediatr. 85 671-673.
275. National Committee for Clinical Laboratory Standards: Performance Standards for Antimicrobial Testing. Tenth informational supplement (aerobic dilution). M100-S10(M7) Table 2G. MIC Interpretive Standards (mg/mL) for Streptococcus pneumoniae. Wayne, PA, NCCLS, January 2000.
276. W. Neches and M. Platt (1968) Cerebrospinal fluid LDH in 287 children including 53 cases of meningitis of bacterial and non-bacterial etiology. Pediatrics 41 1097-1103.
277. B. Negrini, K.J. Kelleher and E.R. Wald (2000) Cerebrospinal fluid findings in aseptic versus bacterial meningitis. Pediatrics 105 316-319.
278. U.M. Niemoller and M.G. Tauber (1989) Brain edema and increased intracranial pressure in the pathophysiology of bacterial meningitis. Eur. J. Clin. Microbiol. Infect. Dis. 8 109-117.
279. R. Novak, B. Henriques, E. Charpentier, et al. (1999) Emergency of vancomycin tolerance in Streptococcus pneumoniae. Nature 399 590-593.
280. J.P. Nuorti, J.C. Butler, M.M. Farley, et al. (2000) Cigarette smoking and invasive pneumococcal disease. N. Engl. J. Med. 342 681-689.
281. C.M. Odio, I. Faingezicht and M. Paris (1991) The beneficial effects of early dexamethasone administration in infants and children with bacterial meningitis. N. Engl. J. Med. 324 1515-1531.
282. C.M. Odio, J.R. Puig, J.M. Feris, et al. (1999) Prospective, randomized investigator-blinded study of the efficacy and safety of meropenem vs. cefotaxime therapy in bacterial meningitis in children. Pediatr. Infect. Dis. J. 18 581-590.
283. C. Olivier, R. Cohen, P. Begue, et al. (2000) Bacteriologic outcome of children with cefotaxime- or ceftriaxone-susceptible and -nonsusceptible Streptococcus pneumoniae meningitis. Pediatr. Infect. Dis. J. 19 1015-1017.
284. L. Pandit, S. Kumar, I. Karunasagar and I. Karunasagar (2005) Diagnosis of partially treated culture-negative bacterial meningitis using 16S rRNA universal primers and restriction endonuclease digestion. J. Med. Microbiol. 54 539-542.
285. J.C. Parke Jr., R. Schneerson and J.B. Robbins (1972) The attack rate, age, incidence, racial distribution and case fatality rate of Hemophilus influenzae, type b meningitis in Mecklenburg County, North Carolina. J. Pediatr. 81 765-769.
286. J. Parkkinen, T.K. Korhonen, A. Pere, et al. (1988) Binding sites in the rat brain for Escherichia coli S fimbriae associated with neonatal meningitis. J. Clin. Invest. 81 860-865.
287. H. Peltola, P.H. Makela, H. Kayhty, et al. (1977) Clinical efficacy of meningococcus group A capsular polysaccharide vaccine in children three months to five years of age. N. Engl. J. Med. 297 686-691.
288. H. Peltola, T.O. Rod, K. Jonsdottir, et al. (1990) Life-threatening Haemophilus influenzae infections in Scandinavia: A five-country analysis of the incidence and the main clinical and bacteriologic characteristics. Rev. Infect. Dis. 12 708-715.
289. M.D. Perkins, S. Mirrett and R.B. Reller (1995) Rapid bacterial antigen detection is not clinically useful. J. Clin. Microbiol. 33 1486-1491.
290. G. Peter, M.B. Weigart, A.R. Bissel, et al. (1981) Meningococcal meningitis in familial deficiency of the fifth component of complement. Pediatrics 67 882-886.
291. M. Pichichero, J. Casey, M. Blatter, et al. (2005) Comparative trial of the safety and immunogenicity of quadrivalent (A, C, Y, W-135) meningococcal polysaccharide-diphtheria conjugate vaccine versus quadrivalent polysaccharide vaccine in two- to ten-year-old children. Pediatr. Infect. Dis. J. 24 57-62.
292. R.W. Pinner, F. Onyango, B.A. Perkins, et al. (1992) Epidemic meningococcal disease in Nairobi, Kenya, 1989. J. Infect. Dis. 166 359-364.
293. S.L. Pomeroy, S.J. Holmes, P.R. Dodge, et al. (1990) A prospective evaluation of the neurologic sequelae of bacterial meningitis in children with special emphasis on late seizures. N. Engl. J. Med. 323 1651-1657.
294. D.A. Powell, M.C. Nahata, D.C. Durrell, et al. (1981) Interactions among chloramphenicol, phenytoin and phenobarbital in a pediatric patient. J. Pediatr. 98 1001-1003.
295. K.R. Powell and S. Mawhorter (1987) Outpatient treatment of serious infections in infants and children with ceftriaxone. J. Pediatr. 110 889-901.
296. K.R. Powell, L.I. Sugarman, A.I. Eskenazi, et al. (1990) Normalization of plasma arginine vasopressin concentrations when children with meningitis are given maintenance plus replacement fluid therapy. J. Pediatr. 117 515-522.
297. C.G. Prober (1995) The role of steroids in the management of children with bacterial meningitis. Pediatrics 95 29-31.
298. V.J. Quagliarello, W.J. Long and W.M. Scheld (1986) Morphologic alterations of the blood brain barrier with experimental meningitis in the rat: Temporal sequence and role of encapsulation. J. Clin. Invest. 77 1084-1095.
299. V.J. Quagliarello and W.M. Scheld (1992) Bacterial meningitis: Pathogenesis, pathophysiology, and progress. N. Engl. J. Med. 327 864-872.
300. P. Radstrom, A. Backman, N. Qian, et al. (1994) Detection of bacterial DNA in cerebrospinal fluid by an assay for simultaneous detection of Neisseria meningitidis, Haemophilus influenzae, and streptococci using a seminested PCR strategy. J. Clin. Microbiol. 32 1738-1744.
301. O. Ramilo, M.M. Mustafa, J. Porter, et al. (1990) Detection of interleukin-1β but not tumor necrosis factor-alpha in cerebrospinal fluid of children with aseptic meningitis. Am. J. Dis. Child. 144 349-352.
302. M.E. Ramsay, N. Andrews, E.B. Kaczmarski, et al. (2001) Efficacy of meningococcal serogroup C conjugate vaccine in teenagers and toddlers in England. Lancet 357 195-196.
303. S. Raziuddin, M.E. El-Awad and N.A. Mir (1991) Bacterial meningitis: T cell activation and immunoregulatory CD4 − T cell subset alteration. J. Allergy Clin. Immunol. 87 1115-1120.
304. J. Reelhuis, M. Honein, C. Whitney, et al. (2003) Risk of bacterial meningitis in children with cochlear implants. N. Engl. J. Med. 349 435-445.
305. E.J. Ridgway, K.D. Allen, T.J. Neal, et al. (1992) Penicillin-resistant pneumococcal meningitis. Lancet 339 931.
306. W.J. Rodriguez, W.N. Khan, B. Gold, et al. (1985) Ceftazidime in the treatment of meningitis in infants and children over one month of age. Am. J. Med. 79(Suppl. 2A), 52-55.
307. W.J. Rodriguez, J.R. Puig, W.N. Khan, et al. (1986) Ceftazidime vs. standard therapy for pediatric meningitis: Therapeutic, pharmacologic and epidemiologic observations. Pediatr. Infect. Dis. 5 408-415.
308. R.J. Roeses and J.C. Campbell (1975) Recovery of auditory function following meningitis deafness. J. Speech Hear. Dis. 40 405-411.
309. L.B. Rorke and F.W. Pitts (1963) Purulent meningitis: The pathological basis of clinical manifestations. Clin. Pediatr. 2 64-71.
310. N.E. Rosenstein, B.A. Perkins, D.S. Stephens, et al. (1999) The changing epidemiology of meningococcal disease in the United States, 1992-1996. J. Infect. Dis. 180 1894-1901.
311. S. Ross, W. Rodriguez, G. Controni, et al. (1975) Limulus lysate test for gram-negative bacterial meningitis: Bedside application. J. A. M. A. 233 1366-1369.
312. H.A. Rotbart (1990) Diagnosis of enteroviral meningitis with the polymerase chain reaction. J. Pediatr. 117 85-89.
313. P.C. Rowe, R.H. McLean, R.A. Wood, et al. (1989) Association of homozygous C4B deficiency with bacterial meningitis. J. Infect. Dis. 160 448-451.
314. F. Russell, J. Carapetis, O. Mansoor, et al. (2003) High incidence of Haemophilus influenzae type b infection in children in Pacific Island Countries. Clin. Infect. Dis. 37 1593-1599.
315. J. Rutledge, D. Benjamin, L. Hood, et al. (1981) Is the CSF lactate measurement useful in the management of children with suspected bacterial meningitis? J. Pediatr. 98 20-24.
316. X. Saez-Llorens, E. Castano, R. Garcia, et al. (1995) Prospective randomized comparison of cefepime and cefotaxime for treatment of bacterial meningitis in infants and children. Antimicrob. Agents Chemother. 39 937-940.
317. X. Saez-Llorens and M. O'Ryan (2001) Cefepime in the empiric treatment of meningitis in children. Pediatr. Infect. Dis. 20 356-361.
318. M.A. Salih, H.S. Ahmed, Z.A. Karrar, et al. (1990) Features of a large epidemic of group A meningococcal meningitis in Khartoum, Sudan, in 1988. Scand. J. Infect. Dis. 22 161-170.
319. O. Sanal, M. Loos, F. Ersoy, et al. (1992) Complement component deficiencies and infection: C5, C8, C3. Eur. J. Pediatr. 151 676-679.
320. U.M. Sankrithi and J.J. Lipuma (1991) Clinically inapparent meningitis complicating periorbital cellulitis. Pediatr. Emerg. Care 7 28-29.
321. M. Santhosham, R. Reid and D.M. Ambrosino (1987) Prevention of Haemophilus influenzae type b infections in high-risk infants treated with bacterial polysaccharide immune globulin. N. Engl. J. Med. 317 923-929.
322. U.B. Schaad, U. Lips, H.E. Gnehm, et al. (1993) Dexamethasone therapy for bacterial meningitis in children. Lancet 342 457-461.
323. U.B. Schaad, S. Suter, A. Gianella-Borradori, et al. (1990) A comparison of ceftriaxone and cefuroxime for the treatment of bacterial meningitis in children. N. Engl. J. Med. 322 141-147.
324. U.B. Schaad, J. Wedgwood-Krucko and H. Tschaeppeler (1988) Reversible ceftriaxone-associated biliary pseudolithiasis in children. Lancet 2 1411-1413.
325. Scheifele, D., Daum, R., Syriopoulou, V., et al.: A primate model of Hemophilus influenzae type b meningitis. 16th Interscience Conference on Antimicrobial Agents and Chemotherapy, Chicago, October 27-29, 1976. Abstract 238.
326. D.W. Scheifele, J.I. Ward and G.R. Siber (1981) Advantage of latex agglutination over countercurrent immunoelectrophoresis in the detection of Haemophilus influenzae type b antigen in serum. Pediatrics 68 888-891.
327. W. Scheld, U. Koedel and B. Nathan (2002) Pathophysiology of bacterial meningitis: Mechanism(s) of neuronal injury. J. Infect. Dis. 186(Suppl 2), S225-S233.
328. W.M. Scheld (1981) Pathophysiological correlates in bacterial meningitis. J. Infect. 3(Suppl. 1), 5-18.
329. W.M. Scheld (1985) Pathogenesis and pathophysiology of pneumococcal meningitis. M.A. Sande, A.L. Smith, R.K. Root (Eds) Bacterial Meningitis New York: Churchill Livingstone 37-69.
330. W.F. Schlech, J.L. Ward, J.D. Band, et al. (1985) Bacterial meningitis in the United States, 1978-1981: The National Bacterial Meningitis Surveillance Study. J. A. M. A. 253 1749-1954.
331. Y. Schlesinger, M.H. Sawyer and G.A. Storch (1994) Enteroviral meningitis in infancy: Potential role for polymerase chain reaction in patient management. Pediatrics 94 157-162.
332. K.C. Schoendorf, W.G. Adams, J.L. Kiely, et al. (1994) National trends in Haemophilus influenzae meningitis mortality and hospitalization among children, 1980 through 1991. Pediatrics 93 663-668.
333. A. Schuchat, K. Robinson, J.D. Wenger, et al. (1997) Bacterial meningitis in the United States in 1995. N. Engl. J. Med. 337 970-976.
334. T. Schuurman, R.F. de Boer, A.M.D. Kooistra-Smid and A.A. van Zwet (2004) Prospective study of use of PCR amplification and sequencing of 16S ribosomal DNA from cerebrospinal fluid for diagnosis of bacterial meningitis in a clinical setting. J. Clin. Microbiol. 42 734-740.
335. B. Schwartz, A. Al-Tobaiqi, A. Al-Ruwais, et al. (1988) Comparative efficacy of ceftriaxone and rifampin in eradicating pharyngeal carriage of group A Neisseria meningitidis. Lancet 1 1239-1242.
336. J.F. Schwartz (1972) Ataxia in bacterial meningitis. Neurology 22 1071-1074.
337. S.H. Sell (1983) Long-term sequelae of bacterial meningitis in children. Pediatr. Infect. Dis. 2 90-93.
338. P.G. Shackelford, J. Campbell and R.D. Feigin (1974) Countercurrent immunoelectrophoresis in the evaluation of childhood infection. J. Pediatr. 85 478-481.
339. A. Sharip, F. Sorvillo, M. Redelings, et al. (2006) Population-based analysis of meningococcal disease mortality in the United States: 1990-2002. Pediatr. Infect. Dis. J. 25 191-194.
340. N. Shetty, P. de Keyser and G.L. Ridgway (1998) Acute bacterial meningitis after dental fillings. J. Infect. 37 89-90.
341. S.B. Shurin and P. Anderson (1983) Anemia associated with H. influenzae b (Hib) septicemia is due to immune hemolysis of RBC coated with soluble bacterial antigens. Pediatr. Res. 17 932.
342. R.H. Sills, M.T. Caserta and S.A. Landaw (1982) Decreased erythrocyte deformability in the anemia of bacterial meningitis. J. Pediatr. 101 395-398.
343. M.D. Simberkoff, N.H. Moldovec and J.J. Rahal Jr. (1980) Absence of detectable bactericidal and opsonic activities in normal and infected human cerebrospinal fluids: A regional host defense deficiency. J. Lab. Clin. Med. 95 362-372.
344. J.I. Singer and O.G. Berger (1981) Simultaneous occult pneumococcal bacteremia in identical twins. J. Pediatr. 98 250-251.
345. S.C. Singhi, P.D. Singhi, B. Srinivas, et al. (1995) Fluid restriction does not improve the outcome of acute meningitis. Pediatr. Infect. Dis. J. 14 495-503.
346. S. Sinner and A. Tunkel (2004) Antimicrobial agents in the treatment of bacterial meningitis. Infect. Dis. Clin. N. Am. 18 581-602.
347. M.M. Sloas, F.F. Barrett, P.J. Chesney, et al. (1992) Cephalosporin treatment failure in penicillin- and cephalosporin-resistant Streptococcus pneumoniae meningitis. Pediatr. Infect. Dis. J. 11 662-666.
348. A.L. Smith (1988) Neurologic sequelae of meningitis. N. Engl. J. Med. 319 1012-1014.
349. D.H. Smith, D.L. Ingram, A.L. Smith, et al. (1973) Bacterial meningitis. Pediatrics 52 586-600.
350. J.F. Smith and B.H. Landing (1960) Mechanisms of brain damage in H. influenzae meningitis. J. Neuropathol. Exp. Neurol. 19 248-265.
351. J.D. Snedeker, S.L. Kaplan, P.R. Dodge, et al. (1990) Subdural effusion and its relationship with neurologic sequelae of bacterial meningitis in infancy: A prospective study. Pediatrics 86 163-170.
352. R.D. Snyder, J. Stovring, A.H. Cushing, et al. (1981) Cerebral infarction in childhood bacterial meningitis. J. Neurol. Neurosurg. Psychiatry 44 581-585.
353. C. Soderstrom, A.G. Sjoholm, R. Svensson, et al. (1989) Another Swedish family with complete properdin deficiency: Association with fulminant meningococcal disease in one male family member. Scand. J. Infect. Dis. 21 259-265.
354. O. Sokolova, N. Heppel, R. Jagerhuber, et al. (2004) Interaction of Neisseria meningitides with human brain microvascular endothelial cells: Role of MAP- and tyrosine kinases in invasion and inflammatory cytokine release. Cell Microbiol. 6 1153-1166.
355. L.M. Sommers and D.S. Hawkins (1999) Meningitis in pediatric cancer patients: A review of forty cases from a single institution. Pediatr. Infect. Dis. J. 18 902-907.
356. P. Sormunen, M.J.T. Kallio, T. Kilpi, et al. (1999) C-reactive protein is useful in distinguishing Gram stain-negative bacterial meningitis from viral meningitis. J. Pediatr. 134 725-729.
357. K.S. Spanaus, D. Nadal, H.W. Pfister, et al. (1997) C-X-C and C-C chemokines are expressed in the cerebrospinal fluid in bacterial meningitis and mediate chemotactic activity on peripheral blood-derived polymorphonuclear and mononuclear cells in vitro. J. Immunol. 158 1956-1964.
358. C.P. Speer, M. Rethwilm and M. Gahr (1987) Elastase-alpha 1-proteinase inhibitor: An early indicator of septicemia and bacterial meningitis in children. J. Pediatr. 111 667-671.
359. J.S. Spika, R.R. Facklam, B.D. Plikaytis, et al., (The Pneumococcal Surveillance Working Group) (1991) Antimicrobial resistance of Streptococcus pneumoniae in the United States, 1979-1987. J. Infect. Dis. 163 1273-1278.
360. E.T. Sproles III, J. Azerrad, C. Williamson, et al. (1969) Meningitis due to Hemophilus influenzae: Long-term sequelae. J. Pediatr. 75 782-788.
361. R.W. Steele and R.W. Bradsher (1983) Comparison of ceftriaxone with standard therapy for bacterial meningitis. J. Pediatr. 103 138-141.
362. R.W. Steele, J.R. McConnell, R.F. Jacobs, et al. (1985) Recurrent bacterial meningitis: Coronal thin-section cranial computed tomography to delineate anatomic defects. Pediatrics 76 950-953.
363. D.S. Stephen and Z.A. McGee (1981) Attachment of Neisseria meningitidis to human mucosal surfaces: Influence of pili and type of receptor cell. J. Infect. Dis. 143 525-532.
364. M. Taha, D. Giorgini, M. Ducos-Galand and J. Alonso (2004) Continuing diversification of Neisseria meningitidis W135 as a primary cause of meningococcal disease after emergence of the serogroup in 2000. J. Clin. Microbiol. 42 4158-4163.
365. T.Q. Tan, E.O. Mason Jr. and S.L. Kaplan (1992) Systemic infections due to Streptococcus pneumoniae relatively resistant to penicillin in a children's hospital: Clinical management and outcome. Pediatrics 90 928-933.
366. T.Q. Tan, E.O. Mason Jr. and S.L. Kaplan (1993) Penicillin-resistant systemic pneumococcal infections in children: A retrospective case-control study. Pediatrics 92 761-767.
367. T.Q. Tan, G.E. Schutze, E.O. Mason Jr., et al. (1994) Antibiotic therapy and acute outcome of meningitis due to Streptococcus pneumoniae considered intermediately susceptible to broad-spectrum cephalosporins. Antimicrob. Agents Chemother. 38 918-923.
368. M.G. Tauber, A.M. Shibl, C.J. Hackbarth, et al. (1987) Antibiotic therapy endotoxin concentration in cerebrospinal fluid and brain edema in experimental Escherichia coli meningitis in rabbits. J. Infect. Dis. 156 456-462.
369. Tauney, A. E., Galvao, P. A., DeMorais, J. S., et al.: Disease prevention by meningococcal serogroup C polysaccharide vaccine in pre-school children—São Paulo, Brazil. Unpublished.
370. H.G. Taylor, E.L. Mills, A. Ciampi, et al. (1990) The sequelae of Haemophilus influenzae meningitis in school-age children. N. Engl. J. Med. 323 1657-1663.
371. D.W. Teele, B. Dashefsky, T. Rakusan, et al. (1981) Meningitis after lumbar puncture in children with bacteremia. N. Engl. J. Med. 305 1079-1081.
372. A. Tejani, B. Dobias and J. Sambursky (1982) Long-term prognosis after H. influenzae meningitis: Prospective evaluation. Dev. Med. Child. Neurol. 24 338-343.
373. A. Tejani, R. Mahadevan and B. Dobias (1981) Occurrence of HLA types in H. influenzae type b disease. Tissue Antigens 17 205-211.
374. K.J. Tracey, J. Vlassara and A. Cerami (1989) Cachectin/tumor necrosis factor. Lancet 1 1122-1125.
375. H. Trujillo, N. Harry, A. Arango, et al. (1989) Aztreonam in the treatment of aerobic, gram-negative bacillary infections in pediatric patients. Chemotherapy 35(Suppl.), 25-30.
376. E. Tuomanen, H. Liu, B. Hengstler, et al. (1985) The induction of meningeal inflammation by components of the pneumococcal cell wall. J. Infect. Dis. 151 859-868.
377. J.E. Tyson, R.C. Gilmartin Jr., B.I. Friedman, et al. (1972) 131I-HSA cisternography in children with meningitis. J.C. Harbert (Eds) Cisternography and Hydrocephalus Springfield, IL: Charles C Thomas 413-432.
378. A. Unkmeir, K. Latsch, G. Dietrich, et al. (2002) Fibronectin mediates Opc dependent internalization of Neisseria meningitidis by human brain microvascular endothelial cells. Mol. Microbiol. 46 933-946.
379. U.S. Department of Commerce, Bureau of the Census (1937) Mortality Statistics, 1935 Washington, D.C.: Government Printing Office
380. U.S. Department of Health, Education and Welfare, Public Health Service (1970) Vital Statistics of the United States, 1968. Vol. II. Mortality Washington, D.C.: Government Printing Office
381. L. van Alphen, L. Spanjaard, A. van der Ende, et al. (1994) Predicted disappearance of Haemophilus influenzae type b meningitis in Netherlands. Lancet 344 195.
382. A.M. van Furth, J.J. Roord and R. van Furth (1996) Roles of proinflammatory and anti-inflammatory cytokines in pathophysiology of bacterial meningitis and effect of adjunctive therapy. Infect. Immun. 64 4883-4890.
383. K.E. van Vliet, M. Glimaker, P. Lebon, et al. (1998) Multicenter evaluation of the Amplicor Enterovirus PCR test with cerebrospinal fluid from patients with aseptic meningitis. J. Clin. Microbiol. 36 2652-2657.
384. M.H. Veeder, J.D. Folds, W.J. Yount, et al. (1981) Recurrent bacterial meningitis associated with C8 and IgA deficiency. J. Infect. Dis. 144 399-402.
385. H. Vienny, P.A. Despland, J. Lutschg, et al. (1984) Early diagnosis and evolution of deafness in childhood bacterial meningitis: A study using brainstem auditory evoked potentials. Pediatrics 73 579-586.
386. A. Waage, A. Halstensen and T. Espevik (1987) Association between tumour necrosis factor in serum and fatal outcome in patients with meningococcal disease. Lancet 1 355-357.
387. M.H. Wahden, F. Rizk and A.M. El-Akkad (1973) A controlled field trial of a serogroup A meningococcal polysaccharide vaccine. Bull. World Health Organ. 48 667-673.
388. E.R. Wald, S.L. Kaplan, E.O. Mason Jr., et al. (1995) Dexamethasone therapy for children with bacterial meningitis. Pediatrics 95 21-28.
389. F.A. Waldvogel (1982) Pathophysiological mechanisms in pneumococcal infection: Two examples—pleural empyema and acute bacterial meningitis. G. Majno, R.S. Cotran, N. Kaufman (Eds) Current Topics in Inflammation and Infection Baltimore: Williams & Wilkins 115-122.
390. J.A. Waler and M.H. Rathore (1995) Outpatient management of pediatric bacterial meningitis. Pediatr. Infect. Dis. J. 14 89-92.
391. J.I. Ward, D.W. Fraser, L.J. Baraff, et al. (1979) Hemophilus influenzae meningitis: A national study of secondary spread in household contacts. N. Engl. J. Med. 19 122-126.
392. J.I. Ward, C. Gorman, C. Philips, et al. (1978) Haemophilus influenzae type b disease in a day care center. J. Pediatr. 92 713-717.
393. J.I. Ward, M.K.W. Lum, D.B. Hall, et al. (1986) Invasive Haemophilus influenzae type b disease in Alaska: Background epidemiology for a vaccine efficacy trial. J. Infect. Dis. 153 17-26.
394. J.I. Ward, G.I. Siber, D.W. Scheifele, et al. (1978) Rapid diagnosis of Hemophilus influenzae type b infections by latex particle agglutination and counterimmunoelectrophoresis. J. Pediatr. 93 37-42.
395. J. Watt, O. Levine and M. Santosham (2003) Global reduction of Hib disease: What are the next steps?. Proceedings of the meeting in Scottsdale, Arizona, September 22-25, 2002. J. Pediatr. 143(6 Suppl), S163-S187.
396. C.E. Weidmer, T.B. Dunkel, F.S. Pettyjohn, et al. (1971) Effectiveness of rifampin in eradicating the meningococcal carrier state in a relatively closed population: Emergence of resistant strains. J. Infect. Dis. 24 172-178.
397. M.L. Weil (1980) Infections of the nervous system. J.H. Menkes (Eds) Textbook of Child Neurology Philadelphia: Lea & Febiger 276-304.
398. C.G. Whitney, M.M. Farley, J. Hadler, et al. (2000) Increasing prevalence of multi-drug resistant Streptococcus pneumoniae in the United States. N. Engl. J. Med. 343 1917-1924.
399. H.C. Whittle and B.M. Greenwood (1976) Meningococcal meningitis in the northern savanna of Africa. Trop. Doct. 6 99-104.
400. D.N. Williams, L.W. Laughlin and Y.H. Lee (1974) Minocycline: Possible vestibular side-effects. Lancet 2 744-746.
401. B. Wispelwey, A.J. Lesse, E.J. Hansen, et al. (1988) Haemophilus lipopolysaccharide-induced blood brain barrier permeability during experimental meningitis in the rat. J. Clin. Invest. 82 1339-1346.
402. M. Wolff, P. Chavanet, A. Kazmierczak, et al. (1992) Diffusion of cefpirome into the cerebrospinal fluid of patients with purulent meningitis. J. Antimicrob. Chemother. 29A 59-62.
403. M. Wong, B.L. Schlaggar and M. Landt (2001) Postictal cerebrospinal fluid abnormalities in children. J. Pediatr. 138 373-377.
404. V.K. Wong, H.T. Wright Jr., L.A. Ross, et al. (1991) Imipenem/cilastatin treatment of bacterial meningitis in children. Pediatr. Infect. Dis. J. 10 122-125.
405. R.C. Woody and T. Yamauchi (1988) Cerebrospinal fluid cell counts in childhood idiopathic status epilepticus. Pediatr. Infect. Dis. J. 7 298-299.
406. K.M. Zangwell, C.M. Vadheim, A.M. Vannier, et al. (1996) Epidemiology of invasive pneumococcal disease in Southern California: Implications for the design and conduct of a pneumococcal conjugate vaccine efficacy trial. J. Infect. Dis. 174 752-759.
407. W.D. Zollinger, R.E. Mandrell, J.M. Guffiss, et al. (1979) Complex of meningococcal group B polysaccharide and type 2 outer membrane protein immunogenic in man. J. Clin. Invest. 63 836-848.
408. A. Zwahlen, U.E. Nydegger, P. Vaudaux, et al. (1982) Complement-mediated opsonic activity in normal and infected human cerebrospinal fluid: Early response during bacterial meningitis. J. Infect. Dis. 145 635-646.
409. P. Zwijenburg, T. van der Poll, S. Florquin, et al. (2003) Interleukin-18 gene-deficient mice show enhanced defense and reduced inflammation during pneumococcal meningitis. J. Neuroimmun. 138 31-37.
410. G. Zysk, W. Bruck, J. Gerber, et al. (1996) Anti-inflammatory treatment influences neuronal apoptotic cell death in the dentate gyrus in experimental pneumococcal meningitis. J. Neuropathol. Exp. Neurol. 55 722-728.